FindTrial
Sign In

Fluorine F 18-fluoroazomycin Arabinoside

DRUG2 trials

Sponsors

M.D. Anderson Cancer Center, University of California, San Francisco

Conditions

Malignant Breast NeoplasmMalignant Colorectal NeoplasmMalignant Pancreatic NeoplasmMalignant Solid NeoplasmRecurrent Aggressive Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell LymphomaRecurrent Malignant Neoplasm

Phase 1

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients
Active, not recruitingNCT03168737
M.D. Anderson Cancer CenterMalignant Breast Neoplasm, Malignant Colorectal Neoplasm, Malignant Pancreatic Neoplasm +1
Start: 2017-09-22End: 2027-04-30Target: 25Updated: 2026-07-30

Unknown Phase

Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell Therapy
CompletedNCT04409314
University of California, San FranciscoRecurrent Aggressive Non-Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent High Grade B-Cell Lymphoma +9
Start: 2020-04-16End: 2023-08-09Updated: 2023-08-21

Related Papers

Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy.
2023-06-101 citations